Ascend Wellness Holdings (AAWH) Share-based Compensation (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Share-based Compensation of $450000.0 for Q1 2026, up 139.51% quarter-over-quarter from -$1.1 million in Q3 2025.
Ascend Wellness Holdings (AAWH) Share-based Compensation (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Share-based Compensation history runs 7 years deep, the most recent figure standing at $450000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation changed N/A year-over-year to $450000.0; the TTM figure through Mar 2026 stood at $450000.0 (up 110.07% YoY), while the FY2024 annual figure was $6.2 million, down 68.41% from the prior year.
- Share-based Compensation for Q1 2026 stood at $450000.0, up from -$1.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $13.9 million in Q3 2023, with the low at -$10.9 million in Q3 2024.
- The 5-year median for Share-based Compensation is $1.1 million (2025), against an average of $2.4 million.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation tumbled 181.65% in 2022, then jumped 10616.0% in 2024.
- Ascend Wellness Holdings' Share-based Compensation stood at $287000.0 in 2022, then surged by 1920.91% to $5.8 million in 2023, then tumbled by 79.53% to $1.2 million in 2024, then tumbled by 195.96% to -$1.1 million in 2025, then soared by 139.51% to $450000.0 in 2026.
- Business Quant data shows AAWH's Share-based Compensation at $450000.0 in Q1 2026, -$1.1 million in Q3 2025, and $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.20 Bn | 43.24 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.43 Bn | 39.78 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 32.03 Bn | 30.35 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.42 Bn | 19.76 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 12.05 Bn | 11.52 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - | - |
| 10 | Ascend Wellness Holdings | 174.62 Mn | 108.45 Mn | 45.49 Mn | 205,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 499,000.00 |
| Jun 30, 2026 | 499,000.00 |
| Mar 31, 2026 | 450,000.00 |
| Mar 31, 2026 | 450,000.00 |
| Sep 30, 2025 | -1.14 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | -10.94 Mn |
| Sep 30, 2024 | -10.94 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Sep 30, 2023 | 13.88 Mn |
| Sep 30, 2023 | 13.88 Mn |